EMEA: Draft guideline on the clinical investigations of medicinal products for the treatment of pulmonary arterial hypertension
30.01.2009
EMEA:
Draft guideline on the clinical investigations of medicinal products for the treatment of pulmonary arterial hypertension. The main focus of this guideline is pulmonary arterial hypertension PAH, although the guideline can be applied to subgroups 4.1 and 4.2 as well.
Draft guideline on the clinical investigations of medicinal products for the treatment of pulmonary arterial hypertension. The main focus of this guideline is pulmonary arterial hypertension PAH, although the guideline can be applied to subgroups 4.1 and 4.2 as well.
The source of the news: http://www.emea.europa.eu/pdfs/human/ewp/35695408en.pdf
SciencePharma
